Betteromics, a company founded in 2020, has successfully raised $20 million in a Series A financing round, with prominent participation from Sofinnova Partners and Triatomic Capital, along with SHAKTI. Betteromics has developed a clinical-grade Software-as-a-Service platform known as the Omics AI Cloud, aimed at empowering professionals in the life sciences field with cutting-edge AI and computational techniques. This platform is designed to eliminate data silos, allowing users to analyze multi-modal, multi-omics data in a unified environment, ultimately reducing risks and expediting the journey from data generation to AI-driven insights.
The secured funding will be channeled towards expanding the Betteromics team and enhancing marketing and sales efforts, catering to a broad spectrum of life science companies, from startups to large enterprises. Key executives leading Betteromics, including CEO Angela Lai, CTO Chetan Patel, and CPO Jack Menzel, bring a wealth of experience in developing transformative infrastructure at renowned companies like Google and GRAIL.
Betteromics, established with a mission to enable scientists, researchers, and clinicians to gain insights from vast data using advanced computation and AI techniques, offers a platform that streamlines the creation of knowledge graphs, connecting data across various standards and ontologies from different sources. Moreover, the platform is highly committed to compliance, holding certifications such as ISO 9001, ISO 27001, SOC2 Type II, and HITRUST i1, ensuring data traceability and reproducibility from the outset, offering rigorous protocols for sensitive data assets.
The partnerships of Triatomic Capital and Sofinnova Partners emphasize the potential of Betteromics to transform the healthcare landscape by leveraging computational techniques on multi-omics datasets. SHAKTI's involvement underscores the growing importance of AI in reshaping global habits, particularly in healthcare and life sciences.